These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26837004)

  • 1. Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.
    Wanlapakorn N; Ngaovithunvong V; Thongmee T; Vichaiwattana P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2016; 11(2):e0148338. PubMed ID: 26837004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Seroprevalence of pertussis toxin antibody in Manisa province of Turkey, after six years implementation of acellular pertussis vaccine].
    Özbek ÖA; Öktem İMA; Hekimoğlu CH; Sekreter Ö; Emek M; Atasoylu G; Açıkgöz A; Demirpençe N; Ceylan A; Baykal ES; Ünal B
    Mikrobiyol Bul; 2018 Apr; 52(2):180-189. PubMed ID: 29933735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents.
    Hanvatananukul P; Prasarakee C; Sarachai S; Aurpibul L; Sintupat K; Khampan R; Saheng J; Sudjaritruk T
    Int J Infect Dis; 2020 Jul; 96():422-430. PubMed ID: 32387447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.
    Campbell P; McIntyre P; Quinn H; Hueston L; Gilbert GL; McVernon J
    PLoS One; 2012; 7(4):e35874. PubMed ID: 22558249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seroepidemiology of pertussis in 10-15 years old healthy children in Isparta province, Turkey].
    Seçkin H; Ormeci AR; Sandal G; Kaya S
    Mikrobiyol Bul; 2013 Jul; 47(3):507-13. PubMed ID: 23971928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of pertussis in Senegal: a prospective study.
    Gaayeb L; Sarr JB; Ndiath MO; Hanon JB; Debrie AS; Seck M; Schacht AM; Remoué F; Hermann E; Riveau G
    PLoS One; 2012; 7(10):e48684. PubMed ID: 23119090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.
    Socan M; Prosenc K; Vegnuti M
    Wien Klin Wochenschr; 2006 Jun; 118(11-12):336-40. PubMed ID: 16855922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam.
    Maertens K; Hoang TT; Nguyen TD; Caboré RN; Duong TH; Huygen K; Hens N; Van Damme P; Dang DA; Leuridan E
    Clin Infect Dis; 2016 Dec; 63(suppl 4):S197-S204. PubMed ID: 27838673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.
    Syed MA; Ahmed W; Naeem A; Bokhari H
    J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of pertussis in China: need to improve vaccination strategies.
    Xu Y; Wang L; Xu J; Wang X; Wei C; Luo P; Ma X; Hou Q; Wang J
    Hum Vaccin Immunother; 2014; 10(1):192-8. PubMed ID: 24018405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
    McCormack PL
    Drugs; 2012 Sep; 72(13):1765-91. PubMed ID: 22931522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
    Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
    BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.
    Hallander HO; Andersson M; Gustafsson L; Ljungman M; Netterlid E
    APMIS; 2009 Dec; 117(12):912-22. PubMed ID: 20078557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
    Kurova N; Timofeeva EV; Guiso N; Macina D
    Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
    Sompagdee N; Anuwutnavin S; Phongsamart W; Senawong S; Umrod P; Robkhonburi A
    Vaccine; 2020 Mar; 38(12):2725-2733. PubMed ID: 32070680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years.
    Chen Z; Zhang J; Cao L; Zhang N; Zhu J; Ping G; Zhao J; Li S; He Q
    J Infect; 2016 Jul; 73(1):38-44. PubMed ID: 27063282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
    Barug D; Pronk I; van Houten MA; Versteegh FGA; Knol MJ; van de Kassteele J; Berbers GAM; Sanders EAM; Rots NY
    Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.